|
2015 Journal Article Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: Position statement of the myeloma foundation of Australia Medical and Scientific Advisory GroupQuach, H., Joshua, D., Ho, J., Szer, J., Spencer, A., Harrison, S., Mollee, P., Roberts, A. W., Horvath, N., Talaulikar, D., To, B., Zannettino, A., Brown, R., Catley, L., Augustson, B., Jaksic, W., Gibson, J. and Prince, H. M. (2015). Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: Position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal, 45 (3), 335-343. doi: 10.1111/imj.12688 |
|
2015 Journal Article Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory GroupQuach, H., Joshua, D., Ho, J., Szer, J., Spencer, A., Harrison, S. J., Mollee, P., Roberts, A. W., Horvath, N., Talulikar, D., To, B., Zannettino, A., Brown, R., Catley, L., Augustson, B., Jaksic, W., Gibsonm J. and Prince, H. M. (2015). Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group. Internal Medicine Journal, 45 (1), 94-105. doi: 10.1111/imj.12640 |
|
2015 Journal Article Intravenous oxycontin-associated thrombotic microangiopathy treated successfully without plasma exchangeTate, Courtney and Mollee, Peter (2015). Intravenous oxycontin-associated thrombotic microangiopathy treated successfully without plasma exchange. Medical Journal of Australia, 202 (6), 330-332. doi: 10.5694/mja14.01125 |
|
2015 Conference Publication Emergence of Fc gamma RIIb-dominance contributes to resistance to therapeutic antibodies in chronic lymphocytic leukemia patientsBurgess, Melinda, Gill, Devinder, Mapp, Sally, Ellis, Jonathan, Cheung, Catherine, Chambers, Lynne, Mattarollo, Stephen, Mollee, Peter and Saunders, Nicholas (2015). Emergence of Fc gamma RIIb-dominance contributes to resistance to therapeutic antibodies in chronic lymphocytic leukemia patients. XVI International Workshop on Chronic Lymphocytic Leukaemia 2015, Sydney, NSW, Australia, 6–9 September 2015. Abingdon, Oxfordshire, United Kingdom: Taylor & Francis. |
|
2015 Conference Publication Diagnosis of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS/MS) Proteomic AnalysisMollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2015). Diagnosis of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS/MS) Proteomic Analysis. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL United States, 5-8 December 2015. Washington, DC United States: American Society of Hematology. |
|
2015 Conference Publication Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot studyMollee, P., Law, W. Phillip, Wang, W. Y. S, Moore, P. T. and Ng, A. C. T (2015). Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study. International Myeloma Workshop, Rome, Italy, 23-26 September 2015. New York, NY United States: Elsevier. doi: 10.1016/j.clml.2015.07.416 |
|
2014 Journal Article Lenalidomide and dexamethasone in transplant-ineligible patients with myelomaBenboubker, Lotfi, Dimopoulos, Meletios A, Dispenzieri, Angela, Catalano, John, Belch, Andrew R, Cavo, Michele, Pinto, Antonello, Weisel, Katja, Ludwig, Heinz, Bahlis, Nizar, Banos, Anne, Tiab, Mourad, Delforge, Michel, Cavenagh, Jamie, Geraldes, Catarina, Lee, Je-Jung, Chen, Christine, Oriol, Albert, de la Rubia, Javier, Qiu, Lugui, White, Darrell J, Binder, Daniel, Anderson, Kenneth, Fermand, Jean-Paul, Moreau, Philippe, Attal, Michel, Knight, Robert, Chen, Guang, Van Oostendorp, Jason ... Mollee, Peter (2014). Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma. The New England Journal of Medicine, 371 (10), 906-17. doi: 10.1056/NEJMoa1402551 |
|
2014 Journal Article Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patientsJackson, Kathryn, Kennedy, Glen, Mollee, Peter, Marlton, Paula and Morris, Kirk (2014). Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients. Asia-Pacific Journal of Clinical Oncology, 10 (3), 246-254. doi: 10.1111/ajco.12188 |
|
2014 Journal Article Successful treatment of iatrogenic multicentric castleman's disease arising due to recrudescence of HHV-8 in a liver transplant patientSpeicher, D. J., Sehu, M. M., Mollee, P., Shen, L., Johnson, N. W. and Faoagali, J. L. (2014). Successful treatment of iatrogenic multicentric castleman's disease arising due to recrudescence of HHV-8 in a liver transplant patient. American Journal of Transplantation, 14 (5), 1207-1213. doi: 10.1111/ajt.12693 |
|
2014 Journal Article Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndromeTan, P., Wei, A., Mithraprabhu, S., Cummings, N., Liu, H. B., Perugini, M., Reed, K., Avery, S., Patil, S., Walker, P., Mollee, P., Grigg, A., D'Andrea, R., Dear, A. and Spencer, A. (2014). Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood Cancer Journal, 4 (1) e170, e170-e170. doi: 10.1038/bcj.2013.68 |
|
2014 Journal Article How to diagnose amyloidosisMollee, P., Renaut, P., Gottlieb, D. and Goodman, H. (2014). How to diagnose amyloidosis. Internal Medicine Journal, 44 (1), 7-17. doi: 10.1111/imj.12288 |
|
2014 Conference Publication New diagnostic strategies for assessment of amyloidosis and myelomaMollee, Peter (2014). New diagnostic strategies for assessment of amyloidosis and myeloma. 48th Annual Scientific Meeting of the Australasian Division of the IAP, Brisbane, QLD Australia, 31 May – 2 June 2024. Oxford, United Kingdom: Elsevier. doi: 10.1097/01.pat.0000443473.89668.b2 |
|
2014 Journal Article Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometryAdams, Rebecca L. C., Cheung, Catherine, Banh, Raymond, Saal, Russell, Cross, Donna, Gill, Devinder, Self, Marlene, Klein, Kerenaftali and Mollee, Peter (2014). Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry. Cytometry Part B - Clinical Cytometry, 86 (2), 80-90. doi: 10.1002/cyto.b.21138 |
|
2014 Conference Publication Recommendations for Serum Free Light Chains (Sflc) Measurement in Routine LaboratoriesTate, Jill, Jovanovich, Sue, Mollee, Peter, Chiu, Weldon, Wienholt, Louise, Gillis, David, Reibelt, Lindsay and Youdell, Odette (2014). Recommendations for Serum Free Light Chains (Sflc) Measurement in Routine Laboratories. Unknown, Unknown, Unknown. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. |
|
2013 Journal Article Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosisMollee, Peter, Tate, Jill and Pretorius, Carel J. (2013). Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis. Clinical Chemistry and Laboratory Medicine, 51 (12), 2303-2310. doi: 10.1515/cclm-2013-0361 |
|
2013 Conference Publication Rapid Molecular Diagnosis Of JAK2V617F Negative MPN By Targeted Deep Sequencing Using The Ion Torrent PGMKlose, Nathan, Tallack, Michael R, Magor, Graham, Mollee, Peter and Perkins, Andrew C (2013). Rapid Molecular Diagnosis Of JAK2V617F Negative MPN By Targeted Deep Sequencing Using The Ion Torrent PGM. 55th ASH Annual Meeting, New Orleans, LA, 7-10 December 2013. American Society of Hematology. doi: 10.1182/blood.v122.21.4093.4093 |
|
2013 Conference Publication Diagnosis of amyloidosis subtype by laser-capture microdissection (LCM) and tandem mass spectrometry (MS) proteomic analysisMollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2013). Diagnosis of amyloidosis subtype by laser-capture microdissection (LCM) and tandem mass spectrometry (MS) proteomic analysis. 55th ASH Annual Meeting, New Orleans, LA United States, 7-10 December 2013. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v122.21.5295.5295 |
|
2013 Conference Publication Diagnosis Of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS) Proteomic AnalysisMollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2013). Diagnosis Of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS) Proteomic Analysis. 55th Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 07-10, 2013. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2013 Conference Publication Serum levels Of CD178 (Soluble FasL) predict treatment response and survival in chronic lymphocytic leukaemia (CLL)Mollee, Peter, Burgess, Melinda, McMillan, Nigel, Saunders, Nicholas, Cheung, Catherine, Hallek, Michael and Gill, Devinder S (2013). Serum levels Of CD178 (Soluble FasL) predict treatment response and survival in chronic lymphocytic leukaemia (CLL). 55th ASH Annual Meeting, New Orleans, LA, 7-10 December 2013. American Society of Hematology. doi: 10.1182/blood.v122.21.2866.2866 |
|
2013 Journal Article Towards improved measurement of serum free light chains: clinical and laboratory issuesTate, Jill and Mollee, Peter (2013). Towards improved measurement of serum free light chains: clinical and laboratory issues. Biochimica Clinica, 37 (5), 395-404. |
